EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early-onset group B streptococcal disease in African countries and maternal vaccination strategies

Ziyaad Dangor, Anna C Seale, Vuyelwa Baba, Gaurav Kwatra

Frontiers in Public Health · 2023

DOI: 10.3389/fpubh.2023.1214844 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Public Health, 2023. Verfasst von Ziyaad Dangor und 3 weiteren Autor:innen. Beteiligte Einrichtung: South African Medical Research Council, Vaccines and Infectious Diseases Analytics Unit, University of the Witwatersrand, Johannesburg, South Africa. Hauptthemen laut MEDLINE: Pregnancy Complications, Infectious, Streptococcal Vaccines, Streptococcal Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Invasive group B streptococcal (GBS) disease is the commonest perinatally-acquired bacterial infection in newborns; the burden is higher in African countries where intrapartum antibiotic prophylaxis strategies are not feasible. In sub-Saharan Africa, almost one in four newborns with GBS early-onset disease will demise, and one in ten survivors have moderate or severe neurodevelopmental impairment. A maternal GBS vaccine to prevent invasive GBS disease in infancy is a pragmatic and cost-effective preventative strategy for Africa. Hexavalent polysaccharide protein conjugate and Alpha family surface protein vaccines are undergoing phase II clinical trials. Vaccine licensure may be facilitated by demonstrating safety and immunological correlates/thresholds suggestive of protection against invasive GBS disease. This will then be followed by phase IV effectiveness studies to assess the burden of GBS vaccine preventable disease, including the effect on all-cause neonatal infections, neonatal deaths and stillbirths.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy Complications, InfectiousStreptococcal VaccinesStreptococcal InfectionsPregnancyFemaleInfant, NewbornHumansVaccinationAnti-Bacterial AgentsAfrica South of the SaharaStreptococcus agalactiae

Stichwörter der Autor:innen

Group B StreptococcusStreptococcus agalactiaeearly-onset diseaseneonatal sepsisperinatal infections

Substanzen

Streptococcal VaccinesAnti-Bacterial Agents

Autor:innen und Institutionen

  • South African Medical Research Council, Vaccines and Infectious Diseases Analytics Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Bill and Melinda Gates Foundation, Seattle, WA, United States.
  • London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Warwick Medical School, University of Warwick, Coventry, United Kingdom.
  • Department of Obstetrics and Gynaecology, University of the Witwatersrand, Johannesburg, South Africa.
  • Department of Clinical Microbiology, Christian Medical College, Vellore, India.

Zitieren

APA

Dangor, Z., Seale, A. C., Baba, V., & Kwatra, G. (2023). Early-onset group B streptococcal disease in African countries and maternal vaccination strategies. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2023.1214844

Vancouver

Dangor Z, Seale AC, Baba V, Kwatra G. Early-onset group B streptococcal disease in African countries and maternal vaccination strategies. Frontiers in Public Health. 2023. doi:10.3389/fpubh.2023.1214844

BibTeX
@article{Dangor2023,
  author = {Dangor, Ziyaad and Seale, Anna C and Baba, Vuyelwa and Kwatra, Gaurav},
  title = {Early-onset group B streptococcal disease in African countries and maternal vaccination strategies},
  journal = {Frontiers in Public Health},
  year = {2023},
  doi = {10.3389/fpubh.2023.1214844}
}
Kostenlos starten →